Patents for C12R 1 - Micro-organisms (92,025) |
---|
11/24/1994 | CA2162865A1 Method for recombinant production of biologically active polypeptides |
11/24/1994 | CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells |
11/24/1994 | CA2162370A1 Composition of antibodies against hepatitis b surface antigen |
11/24/1994 | CA2162022A1 Processes for producing an enzyme |
11/24/1994 | CA2161973A1 Yeast strain and methods for expressing heterologous proteins in yeast |
11/24/1994 | CA2161807A1 Bmp-10 compositions |
11/24/1994 | CA2160458A1 Cho cell sialidase by recombinant dna technology |
11/24/1994 | CA2139665A1 Cloning and expression of the malolactic enzyme gene of lactococcus lactis |
11/24/1994 | CA2139001A1 Combined action of endoglucanases and cellobiohydrolases |
11/23/1994 | EP0625579A1 Streptococcus zooepidemicus mutant strain for preparing hyaluronic acid |
11/23/1994 | EP0625577A1 Heterologous polypeptides expressed in filamentous fungi, processes for their preparation, and vectors for their preparation |
11/23/1994 | EP0625576A2 A gene coding for autonomous replication of a plasmid in Coryneform bacteria |
11/23/1994 | EP0625575A2 Fem A gene of staphylococcus epidermidis, fem A protein, and vectors of microorganisms comprising the fem A gene |
11/23/1994 | EP0625571A2 Microorganisms, their use and method of production of L-alpha-amino acids |
11/23/1994 | EP0625208A1 Biochemical purification of simvastatin |
11/23/1994 | EP0625205A1 Chiral synthesis with modified enzymes |
11/23/1994 | EP0625204A1 Hepatitis therapeutics |
11/23/1994 | EP0625202A1 Serum-human albumin, preparation and utilization |
11/23/1994 | EP0625201A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
11/23/1994 | EP0625200A1 Biosynthetic binding protein for cancer marker |
11/23/1994 | EP0625199A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
11/23/1994 | EP0625197A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof |
11/23/1994 | EP0625193A1 Insecticidally effective peptides |
11/23/1994 | EP0625159A1 Ikaros: a t cell pathway regulatory gene |
11/23/1994 | EP0625053A1 Urease-based vaccine against helicobacter infection |
11/23/1994 | EP0625052A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
11/23/1994 | EP0625049A1 Ex vivo gene transfer |
11/23/1994 | EP0625048A1 Synthesis of human procollagens and collagens in recombinant dna systems |
11/23/1994 | EP0625047A1 Platelet transfusion |
11/23/1994 | EP0556320A4 Monoclonal antibodies to hepatitis c virus and method for using same |
11/23/1994 | CN1095418A Process for production of 6beta,14alpha-dihydroxy-4-androstene-3,17-dione |
11/23/1994 | CN1095416A Hispidospermidin |
11/22/1994 | US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
11/22/1994 | US5366966 Compound UCE6 |
11/22/1994 | US5366890 Alkaloids from cultures |
11/22/1994 | US5366886 Human tissue plasminogen activator variant |
11/22/1994 | US5366883 Genetic engineering |
11/22/1994 | US5366866 Screening for cancer with antibodies |
11/22/1994 | CA1333162C Method for the expression of genes in yeast, and dna fragments as well as plasmids comprising said dna fragments to be used when carrying out the method |
11/22/1994 | CA1333150C Method for the control of pneumocystis carinii |
11/17/1994 | EP0624652A1 Process for producing N-substituted polyhydroxy nitrogen-containing heterocycles |
11/17/1994 | EP0624651A1 Xanthan gum from dairy permeates and other filtered dairy products |
11/17/1994 | EP0624650A2 FemB gene of Staphylococcus epidermidis, FemB protein, and vectors and microorganisms comprising the FemB gen |
11/17/1994 | EP0624644A1 DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector |
11/17/1994 | EP0624641A2 Thermostable nucleic acid polymerase |
11/17/1994 | EP0624376A1 Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci |
11/17/1994 | EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
11/17/1994 | EP0624199A1 Methods for producing thrombin |
11/17/1994 | EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly. |
11/17/1994 | EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
11/17/1994 | EP0624194A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
11/17/1994 | EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
11/17/1994 | EP0563280B1 Tissue plasminogen activator substitution variant |
11/17/1994 | EP0531448B1 Mammalian expression of the bmp-2 family |
11/17/1994 | EP0513133B1 Expression of a multigene rna with self-splicing activity |
11/17/1994 | EP0109441B1 Human-human hybridomas for neoplasms |
11/16/1994 | CN1095106A Vaccines |
11/16/1994 | CN1095105A Production of D-pantoic acid and D-pantothenic acid |
11/16/1994 | CN1095069A Novel process |
11/16/1994 | CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
11/15/1994 | US5364940 Microbiological process for hydroxylation of nitrogen-heterocyclic-carboxylic acids |
11/15/1994 | US5364793 Methods for the diagnosis of peripheral nerve damage |
11/15/1994 | US5364786 Pure culture of Agrobacterium sp. which degrades ferric chelates |
11/15/1994 | US5364782 Mutant microbial α-amylases with increased thermal, acid and/or alkaline stability |
11/15/1994 | US5364781 Process for preparing daunorubicin |
11/15/1994 | US5364778 Copolymer production |
11/15/1994 | US5364775 Biosynthesis from collagen by decomposing other amino acids |
11/15/1994 | US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration |
11/15/1994 | US5364771 Genetic engineering |
11/15/1994 | US5364766 Tryptose, lactose, sodium chloride, bile salts, guar gum, phenol red |
11/15/1994 | US5364763 Techniques for preparing specimens for bacterial assays |
11/15/1994 | US5364640 Process for producing alkyl-methyl ketones |
11/15/1994 | US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis |
11/10/1994 | WO1994025617A2 Monoclonal antibodies against ck-mb |
11/10/1994 | WO1994025612A2 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
11/10/1994 | WO1994025611A1 Integrative dna segment comprising gene encoding insecticidal protein |
11/10/1994 | WO1994025606A2 Recombinant alanine racemase and gapdh from tolypocladium |
11/10/1994 | WO1994025604A2 Steroid 21-hydroxylase fragments and assays using the same |
11/10/1994 | WO1994025603A1 Cholesterol-oxidase from brevibacterium sterolicum |
11/10/1994 | WO1994025600A1 Recombinant antigens from mumps virus and their use in vaccines |
11/10/1994 | WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins |
11/10/1994 | WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
11/10/1994 | WO1994025594A2 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
11/10/1994 | WO1994025592A1 A novel gene coding human epidermal growth factor and process for preparing the same |
11/10/1994 | WO1994025582A1 Method of enhancing thrombolysis |
11/10/1994 | WO1994025580A1 A method for hydrolysing proteins |
11/10/1994 | WO1994025578A1 New lipase variants for use in detergent applications |
11/10/1994 | WO1994025577A1 Lipase variants |
11/10/1994 | WO1994025574A1 L-amino acid oxidase |
11/10/1994 | WO1994025567A1 CLONING AND EXPRESSION OF THE CHONDROITINASE I AND II GENES FROM $i(P. VULGARIS) |
11/10/1994 | WO1994025566A1 1-n-ethyl gentamicin derivatives, and the method for preparing thereof |
11/10/1994 | WO1994025565A1 HUMAN $i(SYK) |
11/10/1994 | WO1994025564A1 Viable bacteria |
11/10/1994 | WO1994025491A1 Fibrin-targeted inhibitors of thrombin |
11/10/1994 | WO1994025486A1 Improved hcv diagnostic agents |
11/10/1994 | WO1994025476A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
11/10/1994 | WO1994025404A1 Microbial degradation of chemical pollutants |
11/10/1994 | WO1994025055A1 Erythropoietin analog compositions and methods |
11/10/1994 | WO1994025022A1 Rapamycin conjugates and antibodies |
11/10/1994 | WO1994025000A1 Hookworm anticoagulant |